REBIF is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Emd Serono, Inc.. The primary component is Interferon Beta-1a.
Product ID | 44087-0044_0b175df7-7507-4d2f-bddf-65f707392420 |
NDC | 44087-0044 |
Product Type | Human Prescription Drug |
Proprietary Name | REBIF |
Generic Name | Interferon Beta-1a |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2002-03-07 |
Marketing Category | BLA / BLA |
Application Number | BLA103780 |
Labeler Name | EMD Serono, Inc. |
Substance Name | INTERFERON BETA-1A |
Active Ingredient Strength | 44 ug/.5mL |
Pharm Classes | Interferon-beta [CS],Recombinant Human Interferon beta [EPC],Recombinant Proteins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2002-03-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103780 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2002-03-07 |
Marketing Category | BLA |
Application Number | BLA103780 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-02-10 |
Ingredient | Strength |
---|---|
INTERFERON BETA-1A | 44 ug/.5mL |
SPL SET ID: | c6fcb5d2-8fcd-44fa-a838-b84ee5f44f0f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
44087-0022 | REBIF | INTERFERON BETA-1A |
44087-0044 | REBIF | interferon beta-1a |
44087-8822 | Rebif | interferon beta-1a |
59627-002 | Avonex | Interferon Beta-1a |
44087-0188 | REBIF REBIDOSE | INTERFERON BETA-1A |
44087-3322 | REBIF REBIDOSE | INTERFERON BETA-1A |
44087-3344 | REBIF REBIDOSE | INTERFERON BETA-1A |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
REBIF 76670527 3674843 Live/Registered |
MERCK KGAA 2006-12-19 |
REBIF 76221340 2558537 Live/Registered |
Ares Trading S.A. 2001-03-07 |
REBIF 74322637 1807009 Live/Registered |
ARES TRADING S.A. 1992-10-14 |